| Product Code: ETC320739 | Publication Date: Aug 2022 | Updated Date: Mar 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Saudi Arabia`s corticosteroid market witnessed a significant decline in import momentum from 2023 to 2024, with a growth rate of -91.34%. The compound annual growth rate (CAGR) for imports between 2020 and 2024 stood at -42.27%. This sharp downturn may be attributed to shifts in demand patterns or changes in trade policies impacting market stability.

Corticosteroids are pharmaceutical drugs used to treat various medical conditions, including inflammatory and autoimmune disorders. In Saudi Arabia, the corticosteroid market serves healthcare professionals and patients who require these medications for therapeutic purposes. Regulatory oversight ensures the responsible use of corticosteroids to manage health conditions effectively and minimize potential side effects.
The corticosteroid market in Saudi Arabia is driven by a rising incidence of inflammatory and autoimmune diseases. Corticosteroids are commonly prescribed to manage these conditions, and the country`s growing healthcare infrastructure is facilitating their availability. Additionally, an aging population is contributing to the demand for corticosteroids as they are often used to treat age-related ailments such as arthritis. The market is further bolstered by ongoing research and development in pharmaceuticals.
The Saudi Arabia corticosteroid market may encounter challenges related to the affordability and accessibility of these medications. Ensuring that essential corticosteroids are accessible to all segments of the population, including vulnerable groups, is crucial for public health. Balancing affordability, quality, and regulatory compliance poses a complex challenge for pharmaceutical companies.
The Saudi Arabia corticosteroid market witnessed multifaceted effects resulting from the COVID-19 pandemic. Corticosteroids, commonly used for their anti-inflammatory and immunosuppressive properties, found applications in treating severe cases of COVID-19, which led to a surge in demand. This increased demand, combined with disruptions in supply chains and manufacturing due to the pandemic, created a complex scenario for the market. Shortages and supply chain interruptions initially impacted the availability of corticosteroid medications, causing concerns for patients with chronic conditions who rely on these drugs. Moreover, the market also faced regulatory challenges and shifts in healthcare priorities as resources were redirected to combat the pandemic. Despite these challenges, the market showcased its importance in the medical landscape, especially during a global health crisis. As healthcare systems adapted and the understanding of COVID-19 treatment evolved, corticosteroids played a crucial role in managing the severe respiratory symptoms of the disease. This dual impact of increased demand and supply chain disruptions underscored the need for resilient supply chains and adaptable healthcare strategies. In conclusion, the Saudi Arabia corticosteroid market grappled with challenges posed by the pandemic while reinforcing its significance in critical care.
In the corticosteroid market, pharmaceutical companies such as Tabuk Pharmaceuticals, SPIMACO, and Jamjoom Pharmaceuticals are significant players. They manufacture and distribute corticosteroid medications for various medical conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Corticosteroid Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Corticosteroid Market Revenues & Volume, 2022 & 2032F |
3.3 Saudi Arabia Corticosteroid Market - Industry Life Cycle |
3.4 Saudi Arabia Corticosteroid Market - Porter's Five Forces |
3.5 Saudi Arabia Corticosteroid Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Saudi Arabia Corticosteroid Market Revenues & Volume Share, By Administration, 2022 & 2032F |
3.7 Saudi Arabia Corticosteroid Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Saudi Arabia Corticosteroid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring corticosteroid treatments |
4.2.2 Growing awareness about the effectiveness of corticosteroids in managing various medical conditions |
4.2.3 Rising healthcare expenditure and investments in healthcare infrastructure in Saudi Arabia |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines governing the use of corticosteroids |
4.3.2 Presence of alternative treatment options and therapies in the market |
4.3.3 Potential side effects and risks associated with prolonged corticosteroid use |
5 Saudi Arabia Corticosteroid Market Trends |
6 Saudi Arabia Corticosteroid Market, By Types |
6.1 Saudi Arabia Corticosteroid Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Corticosteroid Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 Saudi Arabia Corticosteroid Market Revenues & Volume, By Glucocorticoids, 2022-2032F |
6.1.4 Saudi Arabia Corticosteroid Market Revenues & Volume, By Mineralocorticoids, 2022-2032F |
6.2 Saudi Arabia Corticosteroid Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia Corticosteroid Market Revenues & Volume, By Topical Steroids, 2022-2032F |
6.2.3 Saudi Arabia Corticosteroid Market Revenues & Volume, By Inhaled Steroids, 2022-2032F |
6.2.4 Saudi Arabia Corticosteroid Market Revenues & Volume, By Oral Forms, 2022-2032F |
6.2.5 Saudi Arabia Corticosteroid Market Revenues & Volume, By Systemic Forms, 2022-2032F |
6.2.6 Saudi Arabia Corticosteroid Market Revenues & Volume, By Others, 2022-2032F |
6.3 Saudi Arabia Corticosteroid Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Saudi Arabia Corticosteroid Market Revenues & Volume, By Rheumatology Indications, 2022-2032F |
6.3.3 Saudi Arabia Corticosteroid Market Revenues & Volume, By Skin Allergies, 2022-2032F |
6.3.4 Saudi Arabia Corticosteroid Market Revenues & Volume, By Endocrinology, 2022-2032F |
6.3.5 Saudi Arabia Corticosteroid Market Revenues & Volume, By Gastroenterology, 2022-2032F |
6.3.6 Saudi Arabia Corticosteroid Market Revenues & Volume, By Acute Respiratory Diseases, 2022-2032F |
6.3.7 Saudi Arabia Corticosteroid Market Revenues & Volume, By Others, 2022-2032F |
7 Saudi Arabia Corticosteroid Market Import-Export Trade Statistics |
7.1 Saudi Arabia Corticosteroid Market Export to Major Countries |
7.2 Saudi Arabia Corticosteroid Market Imports from Major Countries |
8 Saudi Arabia Corticosteroid Market Key Performance Indicators |
8.1 Prescription rates of corticosteroids by healthcare providers in Saudi Arabia |
8.2 Patient adherence and compliance to corticosteroid treatment regimens |
8.3 Number of clinical trials and research studies conducted on corticosteroids in Saudi Arabia |
8.4 Adoption rates of newer corticosteroid formulations or delivery methods in the market |
8.5 Patient satisfaction and outcomes related to corticosteroid treatments |
9 Saudi Arabia Corticosteroid Market - Opportunity Assessment |
9.1 Saudi Arabia Corticosteroid Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Saudi Arabia Corticosteroid Market Opportunity Assessment, By Administration, 2022 & 2032F |
9.3 Saudi Arabia Corticosteroid Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Saudi Arabia Corticosteroid Market - Competitive Landscape |
10.1 Saudi Arabia Corticosteroid Market Revenue Share, By Companies, 2025 |
10.2 Saudi Arabia Corticosteroid Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here